Streetbeat News

Products Services

IBRX

The FDA approved ImmunityBio Inc's Anktiva for BCG-unresponsive non-muscle invasive bladder cancer, marking a significant advancement in immunotherapy. The approval follows a previous FDA complete response letter and is based on promising clinical results, including a 62% complete response rate. Anktiva, a first-in-class IL-15 agonist, is expected to be available in the U.S. by mid-May 2024. Following the announcement, IBRX shares rose by 4.65% to $5.17.

Portfolio Pulse from Vandana Singh

April 23, 2024 | 1:54 pm

KULR

KULR Technology Group's stock is trading higher following the announcement that the company has fulfilled an urgent order for a power cell battery deployment for AI-enabled drone and advanced air mobility missions in Ukraine.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 1:50 pm

LI

RIVN

Rivian Automotive, Inc. (NASDAQ:RIVN) announced an Earth Day offer, providing up to $5,000 off on new R1 models for customers trading in select gas-powered vehicles. The offer includes a year of free charging on the Rivian Adventure Network and is valid for deliveries between April 22 and June 30 in the U.S. and Canada. This move comes as Tesla and Li Auto, Inc. (NASDAQ:LI) announced price cuts, with Tesla reducing prices by $2,000 across several models.

Portfolio Pulse from Shanthi Rexaline

April 23, 2024 | 1:48 pm

AMZN

Amazon has announced 'Bedrock Innovations' aimed at enabling customers to develop advanced generative artificial intelligence (AI) solutions. This initiative underscores Amazon's commitment to leading in the AI space and providing cutting-edge tools and platforms for AI development.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 1:43 pm

AFRM

Affirm Holdings' shares have rebounded from their lows following the news of their 'Buy Now, Pay Later' service, initially reported in 2022. This development highlights the growing interest and potential in the 'Buy Now, Pay Later' sector.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 1:30 pm

PLUG

Plug Power shares are trading higher following the announcement that the company has reached nameplate capacity at its hydrogen plants in Georgia and Tennessee.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 1:28 pm

TLSA

Tiziana Life Sciences shares surged following the FDA's approval to enroll additional patients in its intranasal foralumab multiple sclerosis expanded access program.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 1:24 pm

DECK

Deckers Brands' division, Ugg, has reached a significant milestone in its commitment to sustainability by influencing the regenerative agriculture movement, achieving a 1 million acres commitment. This achievement underscores the company's dedication to environmental stewardship and sustainable practices.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 1:22 pm

OLN

PLUG

Plug Power, Inc. (NASDAQ:PLUG) shares rose in premarket trading on Tuesday after announcing it reached nameplate capacity at its hydrogen plants in Georgia and Tennessee, signaling a lower cost of hydrogen and profitable growth ahead. The company also highlighted its joint venture with Olin Corporation (NYSE: OLN) for a Louisiana plant expected to add 15 TPD of liquid green hydrogen to its network by Q3 2024, aiming for a total of 40 TPD of internal production capacity. Additionally, Plug Power has implemented price increases across all offerings to restructure its business model.

Portfolio Pulse from Nabaparna Bhattacharya

April 23, 2024 | 1:21 pm

PTPI

Petros Pharmaceuticals has announced an expansion of its online distribution for the prescription medication STENDRA through a new agreement with Lemonaid Health. This collaboration aims to enhance the marketing and distribution of STENDRA for erectile dysfunction (ED) patients using Lemonaid Health's telemedicine services.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 1:20 pm